Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenePharma
Shanghai, Shanghai Municipality, Chinagenepharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
GenePharma is a leading supplier of custom synthetic RNAs—including siRNAs, gRNAs, mRNAs—and provides open-access platforms for research in gene function analysis, genome editing (CRISPR), and development of RNA-based drugs. The company does not appear to have its own clinical pipeline but enables preclinical/academic/industry research globally with advanced manufacturing capabilities in nucleic acid chemistry[1][2].
- Therapeutic areas
- Other
- Modalities
- Small interfering RNAGuide RNA therapymRNA-based drugsSynthetic oligonucleotide
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on GenePharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenePharma.